$6.75
-0.20-2.88%
Last update: Nov 11, 5:23 PM
Satellos Bioscience Inc (MSLE) Stock Price, Quote, News & History
MSLENASDAQ
Satellos reports six-month interim data showing SAT-3247 improved muscle composition, maintained strength, and remained well-tolerated in DMD.
You can purchase shares of Satellos Bioscience (NASDAQ:MSLE) through any online brokerage.
Other companies in Satellos Bioscience’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Satellos Bioscience has a consensus price target of $21.25.
The stock price for Satellos Bioscience (NASDAQ: MSLE) is $6.88 last updated November 11, 2026 at 5:23 PM EST.
There are no upcoming dividends for Satellos Bioscience.
Satellos Bioscience does not have any upcoming earnings scheduled.
There is no upcoming split for Satellos Bioscience.
Satellos Bioscience is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Satellos Bioscience Inc is a Canadian biotechnology and drug development company. The company is developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. The company's program is focused on developing an oral...
